Cigna Stock News

I present my top 15 high-growth dividend stocks to consider during the month of April.

IHF: A Standout Performer With Strong Future Growth Prospects

The Wall Street firms that we cover here at 24/7 Wall St. all keep a list for their institutional and retail clients of high-conviction stock picks.

Cigna is currently trading at an attractive valuation.

Cigna Corp. (CI) expects to buy back more than $7 billion worth of shares in 2022.

Our Cash Indicator methodology acts as a plan in case of an emergency. This is analogous to the multiple safety systems in a modern automobile, which includes an airbag.

We think that Cigna stock (NYSE: CI) currently is a better pick compared to UnitedHealth stock (NYSE: UNH) in the healthcare sector, given its comparatively lower valuation and better prospects. UNH s

Cigna Corp. ( CI , Financial) has only increased its dividend twice in the last decade, but the first one was a 9,900% increase in 2021 followed by a 12% increase for the upcoming March 24 payment dat

Cigna Corporation with ticker code (CI) now have 25 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The range between the high target price and low target price is between 300 and 230 calculating the mean target price we have 261.48. With the stocks previous close at 241.63 this indicates there is a potential upside of 8.2%. The 50 day MA is 231.91 while the 200 day moving average is 223.26. The company has a market cap of $76,339m. Visit the company website at: https://www.cigna.com [stock_market_widget type="chart" template="basic" color="green" assets=CI" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $82,610m based on the market concensus. Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health servicesluding pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers.

I present my top 15 high-growth dividend stocks to consider during the month of March.

Someone with a lot of money to spend has taken a bullish stance on Cigna (NYSE: CI ). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don''t know. But when something this big happens with CI, it often means somebody knows something is about to happen. So how do we know what this whale just did? Today, Benzinga ''s options scanner spotted 13 uncommon options trades for Cigna. This isn''t normal. The overall sentiment of these big-money traders is split between 76% bullish and 23%, bearish. Out of all of the special options we uncovered, … Full story available on Benzinga.com

(RTTNews) - Health service company Cigna Corp. (CI) announced Monday a series of capital deployment priorities designed to enhance shareholder value and deliver long-term growth. Cigna said it expects to generate over $12 billion of deployable capital in 2022, including $5.4 billion in after-tax proceeds from the previously announced sale of…

Cigna (CI) announced a series of capital deployment priorities for enhancing shareholder value and delivering long-term growth.It expects to generate $12B+ of deployable capital in…

BLOOMFIELD, Conn. , Feb. 28, 2022 /PRNewswire/ -- Global health service company Cigna Corporation (NYSE: CI ) today announced a series of capital deployment priorities designed to enhance shareholder value and deliver long-term growth. Cigna expects to generate over $12 billion of deployable capital in 2022, including $5.4 billion in after-tax proceeds from the previously announced sale of its international life, accident, and supplemental benefits businesses in seven countries. These priorities build on the capital Cigna returned to shareholders in 2021, including $7.7 billion of share repurchase and $1.3 billion in dividends. During Cigna''s February Board of Directors meetings, directors approved an aggregate increase of $6 billion in incremental share repurchase authorization, bringing the company''s total share repurchase authority to $10 billion . Year-to-date, Cigna has repurchased $1.2 billion of its shares. The company expects to deploy in excess of $7 billion for share repurchase this year with Cigna''s equity trading at an attractive and compelling valuation, as the company is not currently contemplating large-scale mergers or acquisitions. "Our plans for significant share repurchase coupled with our recently increased dividend, reinforces the confidence we have in our long-term growth plans and the underlying earnings power of Cigna''s business portfolio.

Health care company Cigna Corp. CI, +3.75% said Monday its board has approved a series of capital deployment moves for 2022, including new share buybacks and strategic investments. The board has appro